Research Articles
Chronic Myelomonocytic Leukemia: The Dual-Natured Blood Cancer
Comprehensive review of Chronic Myelomonocytic Leukemia (CMML) - a rare blood cancer with characteristics of both myelodysplastic syndromes and myeloproliferative neoplasms.
Ofatumumab: A Lifeline for Advanced Leukemia Through a Compassionate Use Program
Exploring the science, clinical application, and impact of Ofatumumab in treating advanced-stage chronic lymphocytic leukemia through the UK compassionate use program.
Hope in the Fight: New Combination Therapy for Advanced MPN
Groundbreaking research on ruxolitinib and decitabine combination therapy for accelerated and blast-phase myeloproliferative neoplasms (MPN-AP/BP).
The U1 Spliceosomal RNA: A Genetic Master Controller Gone Rogue in Leukemia
Discover how U1 spliceosomal RNA mutations drive chronic lymphocytic leukemia and represent a novel non-coding hotspot driver mutation with clinical significance.
Cracking CML's Genetic Code: How Blood Tests Can Predict Treatment Success
Discover how gene expression patterns in blood may predict treatment success for chronic myeloid leukemia patients, enabling personalized therapy approaches.
The Silent Switch: How Gene Silencing Fuels Blood Cancer's Deadliest Turns
Exploring how epigenetic silencing of HOXA genes through DNA hypermethylation drives leukemia progression and treatment resistance.